Cleared Traditional

K112303 - RUBICON SUPPORT CATHETER

K112303 is an FDA 510(k) clearance for RUBICON SUPPORT CATHETER, manufactured by Boston Scientific. The device is a Class 2 Cardiovascular device with product code DQY cleared through the Traditional 510(k) pathway after a 90-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2011
Decision
90d
Days
Class 2
Risk

K112303 is an FDA 510(k) clearance for the RUBICON SUPPORT CATHETER. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Boston Scientific (Maple Grove, US). The FDA issued a Cleared decision on November 9, 2011 after a review of 90 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Boston Scientific devices

FDA 510(k) Submission Details - K112303

510(k) Number K112303 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 11, 2011
Decision Date November 09, 2011
Days to Decision 90 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
35d faster than avg
Panel avg: 125d · This submission: 90d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQY Device Classification - Class 2, Special Controls

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 724
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K112303.
CHOCOLATE PTA BALLOON CATHETER (OVER THE WIRE) GUIDE WIRE (0.014 AND 0.018)
K111738 · Trireme Medical, Inc. · Dec 2011
GUIDELINER V2 CATHETER
K112082 · Vascular Solutions, Inc. · Dec 2011
CLEARWAY RX NB CATHETER
K113112 · Atrium Medical Corp. · Nov 2011
REFLEX BALLON GUIDE CATHETER
K112262 · Reverse Medical Corporation · Nov 2011
ATTAIN LDS 6216A LEFT HEART DELIVERY SYSTEM, ATTAIN ACCESS 6218A LEFT HEART DELIVERY SYSTEM, ATTAIN 6216A AND 6218A GUID
K112917 · Medtronic, Inc. · Oct 2011
REVIVE INTERMEDIATE CATHETER (REVIVE IC)
K112828 · Codman & Shurtleff, Inc. · Oct 2011